DK0415766T3 - Anvendelse af retinoider til reversering af glucocorticoid fremkaldt hudatrofi - Google Patents

Anvendelse af retinoider til reversering af glucocorticoid fremkaldt hudatrofi

Info

Publication number
DK0415766T3
DK0415766T3 DK90309510.7T DK90309510T DK0415766T3 DK 0415766 T3 DK0415766 T3 DK 0415766T3 DK 90309510 T DK90309510 T DK 90309510T DK 0415766 T3 DK0415766 T3 DK 0415766T3
Authority
DK
Denmark
Prior art keywords
retinoids
induced skin
skin atrophy
glucocorticoid induced
reverse
Prior art date
Application number
DK90309510.7T
Other languages
Danish (da)
English (en)
Inventor
James A Mezick
Albert M Kligman
Robert J Capetola
Original Assignee
Ortho Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Pharma Corp filed Critical Ortho Pharma Corp
Application granted granted Critical
Publication of DK0415766T3 publication Critical patent/DK0415766T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Laminated Bodies (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Dental Preparations (AREA)
  • Pens And Brushes (AREA)
DK90309510.7T 1989-08-31 1990-08-30 Anvendelse af retinoider til reversering af glucocorticoid fremkaldt hudatrofi DK0415766T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/401,362 US5019569A (en) 1986-11-03 1989-08-31 Reversal of glucocorticoid-induced skin atrophy

Publications (1)

Publication Number Publication Date
DK0415766T3 true DK0415766T3 (da) 1997-01-27

Family

ID=23587438

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90309510.7T DK0415766T3 (da) 1989-08-31 1990-08-30 Anvendelse af retinoider til reversering af glucocorticoid fremkaldt hudatrofi

Country Status (13)

Country Link
US (1) US5019569A (de)
EP (1) EP0415766B1 (de)
JP (1) JP3061628B2 (de)
AT (1) ATE147265T1 (de)
AU (1) AU634807B2 (de)
DE (1) DE69029625T2 (de)
DK (1) DK0415766T3 (de)
ES (1) ES2098253T3 (de)
GR (1) GR1000723B (de)
IE (1) IE903154A1 (de)
PT (1) PT95150B (de)
SG (1) SG50453A1 (de)
ZA (1) ZA906931B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5051449A (en) * 1991-02-27 1991-09-24 Kligman Albert M Treatment of cellulite with retinoids
US5254343A (en) * 1991-03-19 1993-10-19 Bristol-Myers Squibb Company Reduction of cutaneous atrophy
US5268176A (en) * 1991-07-22 1993-12-07 Avon Products, Inc. Method and compositions for the non-invasive treatment of telangiectasia
EP0625045A4 (de) * 1992-02-07 1995-01-18 Albert M Kligman Verfahren zur behandlung von entzündlichen dermatosen.
PT659080E (pt) * 1992-09-11 2001-10-31 Sandra Brown Metodo e composicao cosmeticos para a queda de cabelo
US6344448B1 (en) 1992-09-11 2002-02-05 Stb Family Limited Partnership Composition for the treatment of hair loss
CA2129773C (en) * 1993-09-02 2007-05-01 Michael Klaus Aromatic carboxylic acid derivatives
US6380255B1 (en) 1995-06-07 2002-04-30 Karo Bio Ab Treatment for dermal skin atrophy using thyroid hormone compounds or thyroid hormone-like compounds
US5837224A (en) * 1996-01-19 1998-11-17 The Regents Of The University Of Michigan Method of inhibiting photoaging of skin
UA48212C2 (uk) * 1996-01-31 2002-08-15 Сергей Дмітрієвіч БУРЛАКОВ Антиглюкокортикоїдний лікарський засіб
FR2760362B1 (fr) * 1997-03-10 2000-08-11 Vitasterol Utilisation cosmetique ou dermatologique de steroides 7-hydroxyles
US6008254A (en) * 1997-05-09 1999-12-28 Kligman; Douglas E. Method of treating skin disorders with high-strength tretinoin
US8338648B2 (en) * 2004-06-12 2012-12-25 Signum Biosciences, Inc. Topical compositions and methods for epithelial-related conditions
NO326950B1 (no) * 2006-09-20 2009-03-16 Pharma Medico Res Ltd Kombinasjon av et glukokortikoid og et β-syklodekstrin konjugert vitamin A derivat-kompleks
US11957753B2 (en) 2010-11-22 2024-04-16 Bausch Health Ireland Limited Pharmaceutical formulations containing corticosteroids for topical administration
US8809307B2 (en) 2010-11-22 2014-08-19 Dow Pharmaceutical Sciences, Inc. Pharmaceutical formulations containing corticosteroids for topical administration
HUE050603T2 (hu) 2015-06-18 2020-12-28 Bausch Health Ireland Ltd Egy kortikoszteroidot és egy retinoidot tartalmazó topikális készítmények psoriasis kezelésére
US11311482B2 (en) 2017-05-12 2022-04-26 Bausch Health Us, Llc Topical compositions and methods for treating skin diseases

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3729568A (en) * 1969-09-23 1973-04-24 Johnson & Johnson Acne treatment
US4126693A (en) * 1975-11-03 1978-11-21 Johnson & Johnson Retinoic acid derivatives in the treatment of acne
US4487782A (en) * 1982-03-26 1984-12-11 Ortho Pharmaceutical Corporation Topical treatment of non-inflammatory acne
US4889847A (en) * 1986-11-03 1989-12-26 Ortho Pharmaceutical Corporation Prevention of glucocorticoid-induced skin atrophy
WO1988007857A1 (en) * 1987-04-06 1988-10-20 Daltex Medical Sciences, Inc. Treatment of aged skin with oral 13-cis-retinoic acid

Also Published As

Publication number Publication date
EP0415766A3 (en) 1992-04-08
SG50453A1 (en) 1998-07-20
PT95150B (pt) 1997-06-30
DE69029625T2 (de) 1997-05-28
AU6198790A (en) 1991-03-07
IE903154A1 (en) 1991-03-13
GR900100644A (en) 1991-12-30
AU634807B2 (en) 1993-03-04
ES2098253T3 (es) 1997-05-01
ATE147265T1 (de) 1997-01-15
DE69029625D1 (de) 1997-02-20
EP0415766A2 (de) 1991-03-06
GR1000723B (el) 1992-11-23
EP0415766B1 (de) 1997-01-08
JPH03141218A (ja) 1991-06-17
US5019569A (en) 1991-05-28
PT95150A (pt) 1991-05-22
JP3061628B2 (ja) 2000-07-10
ZA906931B (en) 1992-05-27

Similar Documents

Publication Publication Date Title
AU634807B2 (en) Reversal of glucocorticoid-induced skin atrophy
ATE104845T1 (de) Tocopherolsorbat und entzuendungshemmende wirkstoffe enthaltende lichtschutzmittel.
ES553821A0 (es) Un procedimiento para la preparacion de nuevas azetidinonas sustituidas.
EP0266992A3 (de) Verhütung von glukocorticoid-induzierter Hautatrophie
PT641343E (pt) Derivados de 4-mercaptoacetilamino-¬2|benzazapinona (3) e a sua utilizacao como inibidores de encefalinase
DE68901043D1 (de) Waessriges pharmazeutisches praeparat.
FI946058L (fi) Paikalliseen käyttöön tarkoitettu galeeninen koostumus
MX9204268A (es) Una composicion para la liberacion prolongada y controlada de substancias medicamentosas y un proceso para preparar la misma.
DK683987D0 (da) Topisk farmaceutisk praeparat til anvendelse i form af tape
ES2099764T3 (es) Formulacion a base de diltiazem.
DK463989A (da) Farmaceutisk virksom kombination
ES2101230T3 (es) Nuevos derivados de sustancias anti-inflamatorias, analgesicas y/o antipireticas no estereoideas, su uso y formulaciones farmaceuticas que las contienen.
MX9204563A (es) Nuevos derivados de la (2-alquil-3-piridil)-metilpiperazina y composicion farmaceutica que los comprende.
ES2045484T3 (es) Nuevos derivados de la vitamina d: aplicaciones terapeuticas y a las dosificaciones de los metabolitos de la vitamina d.
DK627289D0 (da) Anvendelse af bicyclononanderivater
DE58903964D1 (de) Fluessige orale formulierung.
DK0437225T3 (da) Topiske præparater
DK0470431T3 (da) Anvendelse af farmaceutisk acceptable fosfomycinsalte som topisk cicatriceringsmiddel
BG50834A3 (en) Method for the preparation of 3- acyl- 2- oxindole- 1- carboxamides
IT8721981A0 (it) Composizione farmaceutica antiinfiammatoria ad effetto prolungato ad uso topico
NO180485C (no) NMDA-antagonister
ES2062313T3 (es) 13-bromo- y 13,14-dibromo-ergolinas, a su preparacion y a su utilizacion en medicamentos.
ES2061847T3 (es) Antibiotico ge 2270.
ES2125884T3 (es) Hexahidrobenzo(f)quinolinonas como inhibidores de la 5-alfa-reductasa.
ATE17857T1 (de) Pharmazeutische praeparate enthaltend d-homo-4,17- androstadien-3-on.